Clinical trial
A Phase I/II Clinical Study of Avapritinib in Chinese Subjects With Unresectable or Metastatic Gastrointestinal Stromal Tumor
NCT04254939 is registered in ClinicalTrials.gov with CStone Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Clinical Study of Avapritinib in Chinese Subjects With Unresectable or Metastatic Gastrointestinal Stromal Tumor
- Lead sponsor
- CStone Pharmaceuticals
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 15, 2019
- Completion date
- April 11, 2023
- Enrollment
- 65 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.